Vyvanse and Amphetamine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Amphetamine (amphetamine). Common drug interactions include fatigue among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Amphetamine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Amphetamine?
Amphetamine has active ingredients of amphetamine. eHealthMe is studying from 980 Amphetamine users. Check the latest studies of Amphetamine.
20 people who take Vyvanse and Amphetamine together, and have interactions are studied.

What are the common drug interactions of Vyvanse and Amphetamine, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Memory impairment
- Sleep disorder
- Abortion spontaneous (naturally occurring miscarriage)
- Blood insulin increased
- Blood iron decreased
- Drug dependence
- Gestational diabetes (diabetes in pregnancy)
- Hypersomnia (excessive daytime sleepiness (eds))
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
male:
- Drug ineffective
- Disturbance in attention
- Acne (skin problems that cause pimples)
- Apathy
- Asthenia (weakness)
- Depressed mood
- Erythema (redness of the skin)
- Eyelid skin dryness
- Hordeolum (small collection of pus (abscess) on the eyelid)
What are the common drug interactions of Vyvanse and Amphetamine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Apathy
- Asthenia (weakness)
- Depressed mood
- Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
- Rash
- Weight decreased
20-29:
- Asthma
- Disturbance in attention
- Drug ineffective
- Fatigue (feeling of tiredness)
- Infection
- Lethargy (tiredness)
- Memory impairment
- Nasopharyngitis (inflammation of the nasopharynx)
- Sleep disorder due to a general medical condition
- Therapeutic response decreased (less preventive response)
30-39:
- Drug ineffective
- Disturbance in attention
- Hypersomnia (excessive daytime sleepiness (eds))
- Antinuclear antibody positive
- Arthralgia (joint pain)
- Blepharospasm (any abnormal contraction or twitch of the eyelid)
- Blood pressure increased
- Chest pain
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Family stress
40-49:
- Anal abscess
- Cellulitis (infection under the skin)
- Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
- Gangrene (body tissue dies)
- Genital abscess (build up of pus in genital)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Perineal abscess
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary tract infection
- Vulval abscess
50-59:
- Sleep disorder
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Balance disorder
- Contusion (a type of hematoma of tissue in which capillaries)
- Dysstasia (difficulty in standing)
- Fall
- Fatigue (feeling of tiredness)
- Gait disturbance
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Speech disorder
60+:
n/a
What are the existing conditions these people have? *
- High Blood Pressure: 2 people, 10.00%
- Drowsiness: 2 people, 10.00%
- Asthma: 2 people, 10.00%
- Bipolar Disorder (mood disorder): 2 people, 10.00%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 10.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.00%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.00%
- Alcoholism (problems with alcohol): 1 person, 5.00%
- Binge Eating (pattern of disordered eating which consists of episodes of uncontrollable eating): 1 person, 5.00%
- Depression: 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and Amphetamine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Vyvanse (35,868 reports)
- Amphetamine (980 reports)
Browse all drug interactions of Vyvanse and Amphetamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Amphetamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amphetamine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and amphetamine (the active ingredients of Vyvanse and Amphetamine, respectively), and Vyvanse and Amphetamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lamivudine cause Blood Urea Increased? - 2 seconds ago
- Could Sertraline Hydrochloride cause Hypercoagulation? - 15 seconds ago
- Could Flaxseed cause Chronic Kidney Disease? - 15 seconds ago
- Drug interactions of Magnesium Glycerophosphate and Gleevec - 20 seconds ago
- Drug interactions of Lialda and Fosamax - 20 seconds ago
- Drug interactions of Novolog and Warfarin Sodium - 24 seconds ago
- Could Vitamin D cause Insomnia Exacerbated? - 26 seconds ago
- Drug interactions of Qvar 40 and Nasacort - 28 seconds ago
- Could Hydramine cause Drug Intolerance? - 29 seconds ago
- Could Fludara cause Hyperplasia? - 29 seconds ago